Ugutz Unzueta

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 25

Top Venues

Pharmaceutics

ACS applied materials & interfaces

Cancers

Diagnostics (Basel, Switzerland)

Universitat Autònoma de Barcelona

Universitat Autònoma de Barcelona (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universitat Autònoma de Barcelona Sep 01 2016

Spain

Associated Professor :: Genetica i Microbiologia

Hospital de la Santa Creu i Sant Pau Institut de Recerca Jan 15 2015

Spain

PhD Researcher :: Grup de Oncogenesi i Antitumorals

Universitat Autònoma de Barcelona Institut de Biotecnologia i de Biomedicina

Spain

PhD Researcher :: Genetica y Microbiologia

Universitat Autònoma de Barcelona Institut de Biotecnologia i de Biomedicina

Spain

PhD Student :: Genetica y Microbiologia

Universitat Autònoma de Barcelona Institut de Biotecnologia i de Biomedicina

Spain

Master Student :: Genetica y Microbiologia

Education History

Universitat Autònoma de Barcelona

Spain

PHD :: Facultat de Biociencies

Universitat Autònoma de Barcelona

Spain

MSC :: Facultat de biociencies

Universitat Autonoma de Barcelona

Spain

BSC :: Facultat de Biociencies

Publications

Anna C Virgili, Juliana Salazar, Alberto Gallardo, Antonio López-Pousa, Raúl Terés, Silvia Bagué, Ruth Orellana, Caterina Fumagalli, Ramón Mangues, Lorena Alba-Castellón, Ugutz Unzueta, Isolda Casanova, Ana Sebio
CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas. Diagnostics (Basel, Switzerland) 14 (11) (2024)
Hèctor López-Laguna, Penelope M Tsimbouri, Vineetha Jayawarna, Ioanna Rigou, Naroa Serna, Eric Voltà-Durán, Ugutz Unzueta, Manuel Salmeron-Sanchez, Esther Vazquez, Matthew John Dalby, Antonio Villaverde
Hybrid Micro-/Nanoprotein Platform Provides Endocrine-like and Extracellular Matrix-like Cell Delivery of Growth Factors. ACS applied materials & interfaces (2024)
Hèctor López-Laguna, Penelope M Tsimbouri, Vineetha Jayawarna, Ioanna Rigou, Naroa Serna, Eric Voltà-Durán, Ugutz Unzueta, Manuel Salmeron-Sanchez, Esther Vazquez, Matthew John Dalby, Antonio Villaverde
Hybrid Micro-/Nanoprotein Platform Provides Endocrine-like and Extracellular Matrix-like Cell Delivery of Growth Factors. ACS applied materials & interfaces 16 (26) (2024)
Hèctor López-Laguna, Penelope M Tsimbouri, Vineetha Jayawarna, Ioanna Rigou, Naroa Serna, Eric Voltà-Durán, Ugutz Unzueta, Manuel Salmeron-Sanchez, Esther Vazquez, Matthew John Dalby, Antonio Villaverde
Hybrid Micro-/Nanoprotein Platform Provides Endocrine-like and Extracellular Matrix-like Cell Delivery of Growth Factors. ACS applied materials & interfaces 16 (26) (2024)
Anna C Virgili, Juliana Salazar, Alberto Gallardo, Antonio López-Pousa, Raúl Terés, Silvia Bagué, Ruth Orellana, Caterina Fumagalli, Ramón Mangues, Lorena Alba-Castellón, Ugutz Unzueta, Isolda Casanova, Ana Sebio
CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas. Diagnostics (Basel, Switzerland) 14 (11) (2024)
Hèctor López-Laguna, Penelope M Tsimbouri, Vineetha Jayawarna, Ioanna Rigou, Naroa Serna, Eric Voltà-Durán, Ugutz Unzueta, Manuel Salmeron-Sanchez, Esther Vazquez, Matthew John Dalby, Antonio Villaverde
Hybrid Micro-/Nanoprotein Platform Provides Endocrine-like and Extracellular Matrix-like Cell Delivery of Growth Factors. ACS applied materials & interfaces 16 (26) (2024)
Yáiza Núñez, Annabel Garcia-León, Aïda Falgàs, Naroa Serna, Laura Sánchez-García, Ana Garrido, Jorge Sierra, Alberto Gallardo, Ugutz Unzueta, Esther Vazquez, Antonio Villaverde, Ramón Mangues, Isolda Casanova
T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo. Pharmaceutics 15 (3) (2023)
Yáiza Núñez, Annabel Garcia-León, Aïda Falgàs, Naroa Serna, Laura Sánchez-García, Ana Garrido, Jorge Sierra, Alberto Gallardo, Ugutz Unzueta, Esther Vazquez, Antonio Villaverde, Ramón Mangues, Isolda Casanova
T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo. Pharmaceutics 15 (3) (2023)
Naroa Serna, Hèctor López-Laguna, Patricia Aceituno, Mauricio Rojas-Peña, Eloi Parladé, Eric Voltà-Durán, Carlos Martínez-Torró, Julieta M Sánchez, Angela Di Somma, Jose Vicente Carratalá, Andrea L Livieri, Neus Ferrer-Miralles, Esther Vázquez, Ugutz Unzueta, Nerea Roher, Antonio Villaverde
Efficient Delivery of Antimicrobial Peptides in an Innovative, Slow-Release Pharmacological Formulation. Pharmaceutics 15 (11) (2023)
Yáiza Núñez, Annabel Garcia-León, Aïda Falgàs, Naroa Serna, Laura Sánchez-García, Ana Garrido, Jorge Sierra, Alberto Gallardo, Ugutz Unzueta, Esther Vazquez, Antonio Villaverde, Ramón Mangues, Isolda Casanova
T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo. Pharmaceutics 15 (3) (2023)
Eric Voltà-Durán, Julieta M Sánchez, Eloi Parladé, Naroa Serna, Esther Vazquez, Ugutz Unzueta, Antonio Villaverde
The Diphtheria Toxin Translocation Domain Impairs Receptor Selectivity in Cancer Cell-Targeted Protein Nanoparticles. Pharmaceutics 14 (12) (2022)
Eloi Parladé, Eric Voltà-Durán, Olivia Cano-Garrido, Julieta M Sánchez, Ugutz Unzueta, Hèctor López-Laguna, Naroa Serna, Montserrat Cano, Manuel Rodríguez-Mariscal, Esther Vazquez, Antonio Villaverde
An In Silico Methodology That Facilitates Decision Making in the Engineering of Nanoscale Protein Materials. International journal of molecular sciences 23 (9) (2022)
Naroa Serna, Aïda Falgàs, Annabel García-León, Ugutz Unzueta, Yáiza Núñez, Alejandro Sánchez-Chardi, Carlos Martínez-Torró, Ramón Mangues, Esther Vazquez, Isolda Casanova, Antonio Villaverde
Time-Prolonged Release of Tumor-Targeted Protein-MMAE Nanoconjugates from Implantable Hybrid Materials. Pharmaceutics 14 (1) (2022)
Esperanza Medina-Gutiérrez, Annabel García-León, Alberto Gallardo, Patricia Álamo, Lorena Alba-Castellón, Ugutz Unzueta, Antonio Villaverde, Esther Vazquez, Isolda Casanova, Ramón Mangues
Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models. Cancers 15 (1) (2022)
Eric Voltà-Durán, Julieta M Sánchez, Eloi Parladé, Naroa Serna, Esther Vazquez, Ugutz Unzueta, Antonio Villaverde
The Diphtheria Toxin Translocation Domain Impairs Receptor Selectivity in Cancer Cell-Targeted Protein Nanoparticles. Pharmaceutics 14 (12) (2022)
Esperanza Medina-Gutiérrez, Annabel García-León, Alberto Gallardo, Patricia Álamo, Lorena Alba-Castellón, Ugutz Unzueta, Antonio Villaverde, Esther Vazquez, Isolda Casanova, Ramón Mangues
Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models. Cancers 15 (1) (2022)
Esperanza Medina-Gutiérrez, María Virtudes Céspedes, Alberto Gallardo, Elisa Rioja-Blanco, Miquel Àngel Pavón, Laura Asensio-Puig, Lourdes Farré, Lorena Alba-Castellón, Ugutz Unzueta, Antonio Villaverde, Esther Vázquez, Isolda Casanova, Ramón Mangues
Novel Endometrial Cancer Models Using Sensitive Metastasis Tracing for CXCR4-Targeted Therapy in Advanced Disease. Biomedicines 10 (7) (2022)
Eric Voltà-Durán, Julieta M Sánchez, Eloi Parladé, Naroa Serna, Esther Vazquez, Ugutz Unzueta, Antonio Villaverde
The Diphtheria Toxin Translocation Domain Impairs Receptor Selectivity in Cancer Cell-Targeted Protein Nanoparticles. Pharmaceutics 14 (12) (2022)
Eric Voltà-Durán, Julieta M Sánchez, Eloi Parladé, Naroa Serna, Esther Vazquez, Ugutz Unzueta, Antonio Villaverde
The Diphtheria Toxin Translocation Domain Impairs Receptor Selectivity in Cancer Cell-Targeted Protein Nanoparticles. Pharmaceutics 14 (12) (2022)
Esperanza Medina-Gutiérrez, Annabel García-León, Alberto Gallardo, Patricia Álamo, Lorena Alba-Castellón, Ugutz Unzueta, Antonio Villaverde, Esther Vazquez, Isolda Casanova, Ramón Mangues
Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models. Cancers 15 (1) (2022)
Laura Sánchez-García, Eric Voltà-Durán, Eloi Parladé, Elisa Mazzega, Alejandro Sánchez-Chardi, Naroa Serna, Hèctor López-Laguna, Mara Mitstorfer, Ugutz Unzueta, Esther Vázquez, Antonio Villaverde, Ario de Marco
Self-Assembled Nanobodies as Selectively Targeted, Nanostructured, and Multivalent Materials. ACS applied materials & interfaces 13 (25) (2021)
Hèctor López-Laguna, Julieta M Sánchez, José Vicente Carratalá, Mauricio Rojas-Peña, Laura Sánchez-García, Eloi Parladé, Alejandro Sánchez-Chardi, Eric Voltà-Durán, Naroa Serna, Olivia Cano-Garrido, Sandra Flores, Neus Ferrer-Miralles, Verónica Nolan, Ario de Marco, Nerea Roher, Ugutz Unzueta, Esther Vazquez, Antonio Villaverde
Biofabrication of functional protein nanoparticles through simple His-tag engineering. ACS sustainable chemistry & engineering 9 (36) (2021)
Naroa Serna, José Vicente Carratalá, Oscar Conchillo-Solé, Carlos Martínez-Torró, Ugutz Unzueta, Ramón Mangues, Neus Ferrer-Miralles, Xavier Daura, Esther Vazquez, Antonio Villaverde
Antibacterial Activity of T22, a Specific Peptidic Ligand of the Tumoral Marker CXCR4. Pharmaceutics 13 (11) (2021)
Naroa Serna, Jose Vicente Carratalá, Eloi Parladé, Alejandro Sánchez-Chardi, Anna Aviñó, Ugutz Unzueta, Ramón Mangues, Ramón Eritja, Neus Ferrer-Miralles, Esther Vazquez, Antonio Villaverde
Developing Protein-Antitumoral Drug Nanoconjugates as Bifunctional Antimicrobial Agents. ACS applied materials & interfaces 12 (52) (2020)
Anna Aviñó, Ugutz Unzueta, María Virtudes Céspedes, Isolda Casanova, Esther Vazquez, Antonio Villaverde, Ramón Mangues, Ramón Eritja
Efficient bioactive oligonucleotide-protein conjugation for cell-targeted cancer therapy. ChemistryOpen 8 (3) (2019)

Ugutz Unzueta.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ugutz Unzueta